Fierce Pharma Week 2025: Building audiences with the same data that built the drug
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce...
Thank you for visiting HealthVerity at Fierce 2025 HealthVerity had a fantastic week at Fierce...
Thank you to everyone who joined us at ISPOR 2025 in Montreal. Whether you stopped by our booth,...
Key benefits of real-world lab data for life sciences and pharma Real-world lab results enhance...
In our ongoing series, we have been discussing the value of real-world data (RWD) throughout the...
Two years ago, HealthVerity launched the Maternal Outcomes Masterset (MOM) to address the...
One in eight women in the U.S. will be diagnosed with breast cancer in their lifetime, that’s one...
In case you missed it, at the end of August, the FDA released new guidance on how to approach...
One in nine Americans age 65 and older has Alzheimer’s disease (AD), a devastating illness that...
Mental health treatment for women who are pregnant or lactating is crucial to ensure positive...
Chronic kidney disease (CKD) is known as a “silent disease” because as many as 90% of patients...
As the new year begins, many patients refocus on weight management and long-term health goals. At the same time, GLP-1 drugs have reshaped the obesity treatment landscape.1,2 With semaglutide and other GLP-1 medications in high demand for weight loss...